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Mitochondrial bioenergetics and biogenesi
Cell wallure lipid of mitochondria, plays a critical role in mitochondrial function and
biogenesis. The availability of yeast mutants blocked in CL synthesis has facilitated studies of the biological
role of this lipid. Perturbation of CL synthesis leads to growth defects not only during respiratory growth but
also under conditions in which respiration is not essential. CL was shown to play a role in mitochondrial
protein import, cell wall biogenesis, aging and apoptosis, ceramide synthesis, and translation of electron
transport chain components. The genetic disorder Barth syndrome (BTHS) is caused by mutations in the
tafazzin gene resulting in decreased total CL levels, accumulation of monolysocardiolipin (MLCL), and
decreased unsaturated fatty acyl species of CL. The variation in clinical presentation of BTHS indicates that
other physiological factors play a signiﬁcant role in modifying the phenotype resulting from tafazzin
deﬁciency. Elucidating the functions of CL is expected to shed light on the role of this important lipid in BTHS
and other disorders of mitochondrial dysfunction.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Cardiolipin (CL) (1,3 diphosphatidyl-sn-glycerol) is a unique and
ubiquitous anionic phospholipid that, in eukaryotes, is localized in the
mitochondrial inner membrane. CL was ﬁrst isolated from beef heart,
hence its name [1]. While it is most abundant in the heart, CL can be
found in all mammalian tissues. Unlike the other membrane
phospholipids, it has a dimeric structure in which two phosphatidyl
moieties are linked by a glycerol [2]. As a result, CL is hydrophobic by
virtue of four fatty acyl groups and acidic due to two phosphates. CL
interacts with a wide variety of mitochondrial proteins by both
hydrophobic and electrostatic interactions [3,4], and stabilizes
proteins in the mitochondrial respiratory chain [5]. CL molecules can
form lamellar or inverted hexagonal structures. The hexagonal phase
is favored in the presence of divalent cations [6]. Although the
biological relevance of these structures is not known, it is plausible
that CL is involved in the formation of local non-bilayer structures
within biological membranes. Such structures are believed to be
involved in membrane fusion and in trans-bilayer movement of
solutes [7]. The ﬁnding that mitochondrial biosynthesis of the non-
bilayer forming phospholipid phosphatidylethanolamine is essential
for the viability of yeast mutants lacking CL suggests a critical role of
CL in the formation of these structures [8], although it should be noted1 313 577 6891.
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l rights reserved.that these structures have not been convincingly demonstrated in
vivo.
The fatty acid composition of CL plays an important role in the
function of the lipid, as aberrant CL remodeling (replacing one fatty
acid with another) underlies the genetic disorder Barth syndrome
(BTHS) [9]. However, no single species of fatty acid is required for
function, as the acyl species of CL from different organisms vary
considerably. Bacterial CL contains saturated and monounsaturated
fatty acyl chains 14–19 carbons in length [10]. Mitochondrial CL is
mainly composed of monounsaturated and diunsaturated fatty acyl
chain of 16–18 carbons in length, resulting in a much higher
unsaturation index than that of bacterial CL. In mammals and higher
plants, the predominant species is linoleic acid, whereas oleic acid and
palmitoleic acid species exist in yeast [11]. In humans, CL acyl species
vary with tissue type, although the predominant species in heart is
tetralinoleoyl CL. This species is absent from BTHS cells [12]. While
speciﬁc CL acyl species vary among eukaryotic cardiolipins, the feature
shared by different organisms is that the dominant species of CL
contains only one or two types of fatty acid. This leads to symmetry
and structural uniformity among cardiolipins [9].
This review focuses on the biosynthesis and function of CL in
eukaryotes, primarily concentrating on yeast, the model in which null
mutants of the genes for CL synthesis are available. The most exciting
ﬁndings pertaining to CL in the last few years are that this
phospholipid plays an important role not only in mitochondrial
bioenergetics, which is not unexpected given the interaction of CL
with mitochondrial proteins, but also in essential cellular functions
not generally associated with respiratory function. Some of these
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tional regulation of electron transport chain (ETC) components, aging,
and apoptosis, and it is likely that this list will be longer in subsequent
reviews. The importance of CL in these and other processes is
underscored by the ﬁnding that mutations in tafazzin, the CL
remodeling enzyme, lead to BTHS. In this paper, CL biosynthesis is
summarized only brieﬂy in order to provide a context in which to
understand the defects in the mutants that have been used to
elucidate function. For a more detailed discussion of the regulation of
CL biosynthesis, we refer the reader to several recent reviews [13,14].
We focus here on studies describing the role of CL in mitochondrial
function and in the essential cellular functions that are not associated
with mitochondrial bioenergetics. In addition, we discuss the role of
CL in BTHS. Finally, we put forward several unanswered questions that
can be exciting areas for further exploration in this ﬁeld.
2. CL biosynthesis
All of the enzymes for de novo synthesis of CL are present in the
mitochondria. As seen in Fig. 1, phosphatidylglycerolphosphate (PGP)
synthase (Pgs1p) catalyzes the committed step, forming PGP from
CDP-DG and glycerol-3-phosphate (G-3-P) [15]. PGP is then depho-
sphorylated to PG by PGP phosphatase [16]. CL synthase (Crd1p)
catalyzes an irreversible condensation reaction in which CDP-DG is
linked to PG via cleavage of a high energy anhydride bond to form CL
[11,17-22]. CL then undergoes remodeling — deacylation leads to the
formation of monolysocardiolipin (MLCL), which is then reacylated
with another fatty acid [23]. In rat liver, mitochondria associated
phospholipase A2 was shown to catalyze the deacylation step to form
MLCL [24]. The yeast enzyme that deacylates CL has not been
identiﬁed. Reacylation is catalyzed by tafazzin [25]. Schlame et al.
demonstrated that tafazzin is a CoA-independent transacylase that
transfers acyl chains preferentially from phosphatidylcholine (PC) to
CL [26]. In a study comparing CL species from a wide variety of
organisms, Schlame et al. showed that the most abundant species of
CL contained only one or two types of fatty acids, which results in a
high degree of structural uniformity and molecular symmetry in
cardiolipins [9]. In contrast, tafazzin-deﬁcient cells were characterized
by multiple species of CL.
The accumulation of MLCL in yeast and human tafazzin-deﬁcient
cells [25,27–29] is consistent with the two step pathway of
remodeling shown in Fig. 1. The importance of remodeling is
underscored by its role in BTHS, a rare X-linked disorder caused by
mutations in tafazzin. BTHS is characterized by cardiomyopathy,Fig. 1. The cardiolipin (CL) biosynthetic pathway: PGS1 encodes phosphatidylglycerol
phosphate (PGP) synthase, which converts glycerol-3-phosphate (G-3-P) and CDP-
diacylglycerol (CDP-DAG) to PGP. PGP is dephosphorylated to phosphatidylglycerol (PG)
by PGP phosphatase. CRD1 encodes CL synthase, which converts CDP-DAG and
phosphatidylglycerol (PG) to CL. In the proposed remodeling pathway, CL is deacylated
to monolysocardiolipin (MLCL) by a phospholipase that has not been identiﬁed. MLCL is
then reacylated to mature CL by Taz1p.skeletal myopathy, neutropenia and growth retardation due to
abnormal mitochondria and defective oxidative phosphorylation
[12]. Patients also exhibit elevated urinary excretion of 3-methylglu-
taconic acid [30] and hypocholesterolemia [31]. BTHS patients display
reduced CL, accumulation of MLCL, and aberrant CL species [24].
The power of the yeast system in elucidating the function of CL
derives from the characterization of the yeast genes that encode
Pgs1p, Crd1p, and Taz1p and the availability of null mutants of these
genes [15,20–22,25,27,28]. These mutants are powerful molecular
tools with which to elucidate the role of CL in vivo. The yeast taz1Δ
null mutant exhibits biochemical defects similar to those observed in
BTHS [14,32–34]. These defects are complemented by expression of
the human tafazzin gene in the taz1Δmutant [25]. Many studies with
the yeast mutants have shown that the CL pathway is required for
optimal mitochondrial function, as discussed in Section 3. The
mutants exhibit growth defects with varying degrees of severity on
non-fermentable carbon sources. The taz1Δ mutant grows poorly on
ethanol at elevated temperature [25,35], crd1Δ exhibits growth
defects at elevated temperature on several carbon sources [35–37],
and pgs1Δ cannot grow at all on non-fermentable carbon sources
[15,38]. Interestingly, pgs1Δ and crd1Δ exhibit growth defects even on
glucose, suggesting that the CL pathway is required for essential
cellular processes not directly associated with respiration. The crd1Δ
mutant exhibits a strain dependent inability to form colonies at
elevated temperature on glucose medium, and pgs1Δ cannot grow at
all at 37 °C on glucose unless supplemented with sorbitol [36,37].
Moreover, pgs1Δ also loses mitochondrial DNA, which may account to
some degree for the inability of the mutant to grow on non-
fermentable carbon sources. The studies summarized in Sections 4–
7 describe cellular functions that are perturbed when CL synthesis is
blocked.
3. CL and mitochondrial bioenergetics
CL is highly enriched in membranes designed to generate an
electrochemical gradient for ATP synthesis, such as the bacterial
plasma membrane [39] and the inner mitochondrial membrane [40].
It is also present in membranes of hydrogenosomes, a mitochondria-
like organelle in protists [41]. This ubiquitous and intimate association
between CL and energy transducing membranes suggests an impor-
tant role for CL in bioenergetic reactions. It is not surprising that a
number of biochemical studies carried out in the 89s and 99s have
identiﬁed interactions between CL and several inner mitochondrial
membrane proteins (Table 1). We refer readers to previous reviews
[3,4] for a more detailed discussion of this subject. CL modulates the
catalytic activities of the interacting proteins, as seen in the ADP–ATP
carrier [42,43] and/or provides stability, as reported for complex III
[44] and complex IV [45]. CL also binds speciﬁcally and irreversibly to
cytochrome c [46], limiting the soluble pool of the protein. Therefore,
it may play an important regulatory role in cytochrome c release,
which triggers the downstream events in apoptosis.
In summary, in vitro studies suggest that CL is involved in site-
directed structure–function relationships with mitochondrial respira-
tory chain complexes and transporters. However, it should be noted
that these studies may not necessarily reﬂect in vivo interactions.
3.1. In vivo studies of the role of CL in mitochondrial respiration
The cloning of the CL synthase gene CRD1 [20–22] and the
construction of crd1Δ yeast cells, which are completely devoid of CL,
provided an excellent model to address the in vivo role of CL.
Subsequent studies led to the surprising observation that crd1Δ cells
can grow in non-fermentable carbon sources (which requires a
functional respiratory chain for viability). This suggested that the
interaction of CL with respiratory chain proteins is not essential for
respiration, perhaps because other phospholipids such as PG and
Table 1
CL interacting proteins in mitochondria
Protein Reference no.
a) Respiratory chain proteins
1) Complex I 6
2) Complex III 6,7,8
3) Complex IV 9,10
4) Complex V 11
5) Cytochrome c 12
b) Transporter/carrier proteins
1) ADP–ATP carrier 13,14
2) Phosphate carrier 15
3) Pyruvate carrier 16
4) Carnitine carrier 17,18
c) Others
1) Cardiolipin synthase 19
2) Creatine kinase 20
3) Glycerol 3-phosphate dehydrogenase 21
4) Carbamoyl phosphate synthetase I 22
5) Cytochrome P450scc 23,24
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able to compensate for the lack of CL [37,47]. Although crd1ΔΔ cells
can grow in non-fermentable carbon sources, the growth rate of the
mutant is reduced, suggesting the presence of mild defects in the
mitochondrial energy transforming machinery. Indeed, bioenergetic
measurements in isolated mitochondria from crd1Δ cells showed that
CL is required for tight coupling (optimal ADP/O ratio and low state 4
respiration) of mitochondria at the maximal rate of respiration [48]
and also for the maintenance of a mitochondrial membrane potential
[35]. Furthermore, CL improved the efﬁciency of oxidative phosphor-
ylation in unfavorable conditions, such as increased temperature and
osmotic shock [48,49]. The molecular basis underlying these physio-
logical defects became clearer after the discovery of the supramole-
cular structural assembly of respiratory chain proteins [50].
3.2. The role of CL in supercomplex assembly
The respiratory chain supercomplexes, ﬁrst reported by Schagger
and Pfeiffer, refer to the organization of electron transport chain
complexes into supramolecular structures [50]. In mammalian
mitochondria, complex I is associated with dimeric complex III and
multiple copies of complex IV (up to 4) resulting in multiple
supercomplexes. In S. cerevisiae mitochondria, which lack complex I,
complex III exists as a free dimer and in two supercomplexes
comprising an additional one or two complex IV monomers, which
are referred to as the small and large supercomplexes, respectively
[50]. Blue-native PAGE (BN-PAGE) analysis of crd1Δ mitochondria
showed a complete absence of these supercomplexes [51]. However,
analysis by milder colorless-native PAGE revealed the presence of
large supercomplexes, suggesting that the anionic dye used in BN-
PAGE induced dissociation of the loosely bound complexes III and IV in
the absence of CL. This implies that supercomplexes exist in the
mutantmitochondria, but the absence of CL signiﬁcantly reduces their
stability [51]. An alternate explanation for the detection of super-
complexes in crd1Δ by CN-PAGE is that highly hydrophobicmembrane
proteins aggregate under the conditions of CN-PAGE in which
membrane complexes migrate through the native gel by virtue of
their intrinsic charges. The experiments by Zhang et al. [52] support
the latter explanation and suggest that CL may be required for the
assembly of supercomplexes. Additional evidence for the role of CL in
respiratory chain supercomplex assembly and stability came from
studies with yeast taz1Δ cells. BN-PAGE analysis of taz1Δ mitochon-
dria showed a decrease in the amount of large supercomplex and an
increase in free complex IV monomer. Additionally, the assembly of
complex IV into supercomplexes is severely affected in taz1Δ mutant
mitochondria [53]. This indicates that CL is critical for the biogenesisof respiratory chain supercomplexes, and that the role of CL in
supercomplex assembly may not be limited to a stabilizing effect.
However, the possibility that Taz1p is a cofactor for the assembly of
respiratory supercomplexes cannot be ruled out. Similar results were
seen in mitochondria from BTHS patients [53]. Furthermore, in BTHS
patient mitochondria, the interaction between complexes I and III was
also less stable, with decreased levels of the complex I/III2 super-
complex. Thus, the decreased CL and/or loss of mature CL species in
BTHS results in unstable respiratory chain supercomplexes, which
may contribute to subsequent pathology. What are the bioenergetic
consequences of the absence of supercomplexes and how do they
contribute to the pathology in BTHS? It has been proposed that
supercomplexes allow substrate channeling and thus prevent leakage
of electrons from the respiratory chain. The leaked electrons can easily
react with oxygen molecules to generate reactive oxygen species
(ROS). Thus, one possible consequence of unstable supercomplexes is
increased oxidative stress, and this may be a contributing factor in the
pathogenesis of BTHS. Consistent with this, Chen et al. observed an
increase in protein carbonylation in yeast taz1Δ cells during
respiratory growth (see Section 6) [54].
4. CL and mitochondrial protein import
More than 98% of mitochondrial proteins are encoded in the
nucleus and synthe.sized as precursors in the cytosol. These
preproteins are imported into the mitochondria via translocases
present in the outer and inner mitochondrial membrane [55]. The
preproteins are targeted to receptor proteins on the outer mitochon-
drial membrane and to general import proteins of the TOM complex
[56]. Transport across the inner membrane is mediated by the TIM
complex [56]. A role for CL in protein import was ﬁrst suggested by
the ﬁnding that protein import was blocked when yeast cells were
treated with the CL-binding compound doxorubicin [57]. Subsequent
studies with the crd1Δ mutant indicated that the absence of CL
leads to a reduced membrane potential and decreased protein
import [35]. More recently a reconstitution study indicated that the
membrane integration of mitochondrial preproteins is most efﬁcient
when a presequence translocase is reconstituted in CL-containing
membranes [58].
4.1. Defective protein import in the absence of CL
Jiang et al. showed that crd1Δ cells exhibit a decreased mitochon-
drial membrane potential as well as defective import of proteins into
mitochondria [35]. The import defect was greater for a preprotein that
required a membrane potential. More recently, a link between BTHS
and protein import was suggested by the ﬁnding that a BTHS-like
illness known as dilated cardiomyopathy with ataxia (DCMA)
syndrome is caused by mutations in the protein import gene
DNAJC19/TIM14 [59]. Like BTHS, DCMA syndrome is characterized
by cardiomyopathy, neutropenia and elevated 3-methylglutaconic
acid. The DNAJC19 protein shares sequence similarity with Tim14p, a
protein that is associated with the inner mitochondrial membrane
motor complex of Tim23p. Because the clinical presentation of DCMA
is very similar to that of BTHS, it is interesting to speculate that the
defect in BTHS may be caused or exacerbated by defective mitochon-
drial protein import.
5. Mitochondrial anionic phospholipids and cell wall biogenesis
Experiments to isolate suppressors of the pgs1Δ temperature
sensitivity phenotype led to the identiﬁcation of a loss of function
mutant of KRE5, a gene involved in cell wall biogenesis [60]. The cell
wall is an essential organelle that determines cell shape and integrity.
It is a dynamic structure that undergoes numerous modiﬁcations in
response to changes in growth phase and environment [61,62]. The
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mannoprotein outer layer, and an inner layer enriched in chitin and
glucan [63]. β-1,3-glucan and chitin together provide mechanical
strength to the cell wall. β-1,3-glucan, the product of the plasma
membrane protein β-1,3-glucan synthase, interconnects cell wall
components [63,64]. Glucan synthase is composed of a catalytic
subunit encoded by homologous genes FKS1 and FKS2 [65, 66], and a
regulatory subunit, Rho1p [64]. Chitin is enriched in and around bud
scars and is increased in number or size upon weakening of the cell
wall [63,67]. Defects in the assembly of cell wall components affect the
cellular response to heat and osmotic stress.
Suppression of pgs1Δ temperature sensitivity by kre5Δ suggested
a connection between the CL pathway and cell wall biogenesis [60],
consistent with the ﬁnding of Lussier et al. that disruption of the PGS1
promoter leads to hypersensitivity to cell wall perturbing agents such
as zymolyase, calcoﬂuor white, papulacandin and caffeine [68].
Biochemical analysis of the cell wall of pgs1Δ indicated that the
mutant has reduced levels of β-1,3-glucan [60]. Consistent with this,
cytological studies revealed that pgs1Δ cells exhibited the enlarged
cell phenotype characteristic of cell wall mutants. Levels of β-1,3-
glucan were increased in the kre5 suppressor mutant, and the
phenotypes of temperature sensitivity and enlarged spherical mor-
phology were suppressed by kre5.
What are the mechanisms linking mitochondrial anionic phos-
pholipids to the cell wall, where these lipids are not present? A clue to
this question comes from the ﬁnding that cell wall defects in the
pgs1Δ mutant are associated with perturbation of the cell integrity
pathway [69]. In this pathway, activation of Pkc1p in response to cell
wall stress results in activation of a cascade of proteins in the Mpk1/
Slt2 mitogen activated protein kinase (MAPK) pathway, culminating
in the activation/dual phosphorylation of Slt2. The dual phosphory-
lated Slt2p activates transcription factors that up-regulate genes
involved in cell wall synthesis [70,71]. Interestingly, the pgs1Δmutant
exhibits defective Slt2p activation, which is restored by the kre5
suppressor [69]. The mechanism linking PG/CL to the Slt2 pathway is
not known.
6. CL is associated with aging and apoptosis
A role for CL has been implicated in the inter-related processes of
aging and apoptosis [72–74], and cells lacking CL exhibit accelerated
entry into apoptosis and an increased level of cell death in response to
stimuli that induce apoptosis [75]. Decreased CL and a loss of
mitochondrial function have been observed in the early stages of
aging in rats and humans [76,77]. An increased content of CL species
containing highly unsaturated acyl groups is also observed in old cells
[78]. CL is required for the loose binding of cytochrome c to the
mitochondrial inner membrane by electrostatic interactions in normal
cells, and PG can only partly compensate for this function [73]. CL is
also required for the function of the adenine nucleotide translocase,
which is a component of the mitochondrial permeability transition
pore [79–81]. It has been proposed that the permeability transition
pore controls a mitochondrial ampliﬁcation cycle in which cyto-
chrome c and other apoptogenic proteins are released from the
mitochondrial intermembrane space into the cytosol [81]. During
apoptosis, CL peroxidation and a decrease in total CL levels result in a
signiﬁcant increase in cytochrome c release into the cytoplasm and an
accumulation of free cytochrome c in the intermembrane space
[73,75,82–84]. The release of cytochrome c represents a central step in
apoptotic signaling [72,83,85]. Interestingly, in addition to loose
binding between cytochrome c and CL, tight binding through
hydrophobic interactions in the inner membrane induces partial
unfolding of cytochrome c and the activation of its peroxidase
catalytic activity [86]. Recent studies showed that cytochrome c is a
catalyst for CL peroxidation, which contributes to permeation of the
mitochondrial outer membrane and release of cytochrome c [87]. Invitro studies showed that cytochrome c has a lower afﬁnity for
peroxidized CL than normal CL [88]. These ﬁndings suggest that
during apoptosis, CL peroxidation caused by peroxidase activity of
cytochrome c may facilitate the release of cytochrome c from both
loose and tight binding with CL.
As discussed above, CL is required for maintaining the stability and
function of electron transport chain supercomplexes [72,89–91]. As a
result, the loss of CL results in respiration defects that may contribute
to the generation of ROS. Increased ROS, which is linked to
mitochondrial dysfunction, triggers both apoptosis and aging
[73,92,93], and is associated with a shortened life span in many
species [94]. CL is particularly susceptible to ROS attack because of its
location in the mitochondrial inner membrane close to the site of ROS
generation, and due to its high content of unsaturated fatty acids that
are highly vulnerable to oxidative damage [84,95]. In this manner,
increased ROS in CL-deﬁcient cells may contribute to a further
decrease in CL.
Chen et al. have shown that, in response to ethanol, CL mutants
taz1Δ and crd1Δ exhibit increased protein carbonylation, an indicator
of ROS [54]. As the presence of paraquat, menadione or hydrogen
peroxide (H2O2) did not lead to severe growth defects in the CL
mutants as compared towild type, the increase in ROSwasmost likely
not due to defective oxidant defense systems. Ethanol sensitivity and
increased protein carbonylation in the taz1Δmutant but not in crd1Δ
were rescued by supplementation with oleic acid, suggesting that
oleoyl-CL and/or oleoyl-MLCL enables growth of taz1Δ in ethanol by
decreasing oxidative stress. The ﬁnding of increased oxidative stress in
the taz1Δ mutant during respiratory growth may have important
implications for understanding the pathogenesis of BTHS [54].
The observations of Chen et al. that growth of crd1 was not
severely affected by H2O2 differed somewhat from a previous report in
which a phenotypic screen of yeast deletion mutants identiﬁed crd1Δ
as sensitive to H2O2 [96]. The most likely reason for the disparity is
that sensitivity was determined differently in the two studies. Chen et
al. compared growth of crd1Δ to mutants in SOD1 and SOD2, which
are extremely sensitive to H2O2, under conditions that would mask
mild sensitivity. In contrast, the experiments in Higgins et al.
compared sensitivity of mutants to wild type cells in short term
incubations, conditions under which mild sensitivity would easily be
detected. It is thus likely that, while loss of CL does not impair SOD1 or
SOD2 mediated antioxidant defense, mild sensitivity of crd1Δ cells to
H2O2 is most likely mediated via a compromised respiratory chain
function, as has been observed in a number of respiratory chain
deletion mutants [97].
7. CL, inositol sphingolipid phospholipase C (Isc1p), and
translational regulation of ETC components
Dowhan et al. made the surprising observation that pgs1Δ exhibits
defective translational regulation of several mitochondria-encoded
ETC components and of Cox4p, a nuclear-encoded component of the
ETC [98]. The translational defect resulted from the lack of PG/CL in
the mitochondrial membrane, as re-introduction of PGS1 on a high
copy plasmid restored expression of Cox4p. RNA levels were not
affected, and in vitro studies indicated that the defect was not due to
decreased protein import but rather to a failure of translation [99].
Deletion analysis of the upstream non-coding region of COX4
suggested that a cis-acting sequence with two stem-loops in the 5′
UTR appeared to be responsible for inhibition of COX4 translation.
Trans-acting factors that bind to this region have not been identiﬁed;
however, binding of a protein factor(s) to this sequence was observed
with cytoplasm from pgs1Δ but not wild type PGS1 cells, and loss of
function mutants that allowed expression of reporter constructs
under control of the COX4 promoter were isolated. These ﬁndings
identify a novel cross talk pathway between mitochondria and the
nucleus, in which translation of nuclear-encoded proteins destined
Fig. 2. Cellular functions of the CL pathway in yeast.
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chondrial anionic lipids PG and/or CL [99].
Defective translation of Cox4p was also seen with the loss of
inositol phosphosphingolipid phospholipase C (Isc1p), a member of
the family of neutral sphingomyelinases that regulate ceramide
synthesis [100]. Isc1p activity is impaired in the pgs1Δ mutant,
suggesting that PG/CL is required for activation of this enzyme [100].
Interestingly, the phenotypic defects of isc1Δ and pgs1Δ are similar,
which suggests that these genes may have overlapping functions.
These ﬁndings led to the speculation that PG regulates translation of
the ETC proteins indirectly by activation of Isc1p.
8. CL and BTHS
The studies cited above indicate that the CL pathway is crucial for
mitochondrial bioenergetics and for essential cellular functions not
generally associated with respiration. It is, therefore, not surprising
that perturbation of this pathway in humans leads to deleterious
consequences. As discussed earlier, BTHS is a disorder resulting from
loss of tafazzin, a CL remodeling enzyme. About ten years after the ﬁrst
description of BTHS, the locus was mapped to Xq28 [101] and
mutations were identiﬁed in G4.5, the tafazzin gene [102]. The link
between CL and BTHS was ﬁrst reported by Peter Vreken et al., who
demonstrated that ﬁbroblast cultures from BTHS patients contain less
CL than control cultures [33]. Furthermore, BTHS cells were defective
in acylation of CL and PG with unsaturated fatty acids. Subsequent
analysis showed that BTHS cells contained a decrease in total CL
content [33] and an accumulation of MLCL [29]. The predominant acyl
species, tetralinoleoyl CL is absent from BTHS cells [12].
Lymphoblast mitochondria from patients with BTHS exhibit
hyperproliferation and abnormalities in energy metabolism [103].
These abnormalities led to impaired coupling, consistent with the
studies in tafazzin-deﬁcient yeast [104]. Due to the adhesion of
opposing membranes, the intracrista space in BTHS mitochondria
appears to be deformed [105], which may explain the decrease in
mitochondrial membrane potential in BTHS [103] and in yeast taz1Δ
[104].
Approximately 28 different mutations resulting in single amino
acid changes in tafazzin have been identiﬁed in BTHS patients [26]. The
mutations result in a complete loss of tafazzin or in expression of a
severely truncated protein [28]. Interestingly, the clinical presentation
of BTHS varies a great deal, from thosewho have severe incapacitating
disease to those who are nearly asymptomatic, even among patients
with identical mutations. This variation indicates that physiological
modiﬁers may play a signiﬁcant role in the BTHS phenotype. Thus,
while it is clear that tafazzin is a CL transacylase, the cellular
consequences of defective tafazzin and themolecular basis underlying
the pathologies observed in BTHS patients are not understood.
Homologues of human tafazzin are present throughout eukaryotic
species from yeast to mammals, and yeast [25,27,28], Drosophila [106]
and zebraﬁsh [107] models of BTHS have been characterized. Genetic
studies in these model systems may help to elucidate the mechanisms
linking tafazzin to the cellular defects in BTHS, and to identify the
physiological modiﬁers of the BTHS phenotype.
9. Future directions
While a great deal has been learned about the biochemical role of
CL from in vitro studies, the availability of yeast CL mutants has
opened the door to in vivo studies of CL function. The studies cited
above indicate that CL plays a role not only in mitochondrial
bioenergetics, but also in cell wall integrity, mitochondrial protein
import, aging and apoptosis, ceramide synthesis, and translational
regulation (Fig. 2). While these studies comprise a promising
beginning to understanding CL function, numerous questions remain
unanswered.The regulation of CL metabolism is not well-characterized. Genes
that mediate the breakdown and turnover of CL and the regulatory
networks that control CL synthesis have not been identiﬁed.
Molecular mechanisms underlying the role of CL in mitochondrial
bioenergetics are only beginning to be understood, and the degree to
which PG can compensate for CL varies with speciﬁc functions. What
are the consequences of defective supercomplex formation associated
with CL deﬁciency? How does the loss of CL lead to increased
generation of ROS? What is the nature of CL interactions with the
proteins of the ETC? What are the trans-acting factors that regulate
translation of ETC proteins in response to PG/CL? These questions
remain to be addressed.
The mechanisms linking PG/CL to the essential cellular functions
described above are not known. What role does PG/CL play in
mitochondrial protein import? Are import defects the indirect results
of perturbation of the membrane potential in CL mutants, or does CL
play a more direct role by interacting with the protein import
machinery? Does DCMA syndrome identify an import defect that is
downstream from perturbation of CL synthesis? The answers to these
questions may help to elucidate the direct or indirect role of CL in
mitochondrial import.
The link between PG/CL and cell wall biogenesis is intriguing and
may shed light on the role of CL in aging. In yeast, cell integrity and the
stress response are inter-related, and both pathways affect longevity
[108–113]. As discussed above, the Pkc1-activated Mpk1/Slt2 MAPK
pathway is defective in pgs1Δ cells in some genetic backgrounds. This
pathway is interconnected with the high osmolarity glycerol (HOG)
MAPK pathway that is activated in response to osmotic and other
stresses [114]. The central kinase HOG1/p38 affects longevity and
replicative capacity [115,116]. There are also several cell wall
associated pathways that affect aging independent of the stress
pathways [110,11]. Because several of these interconnected pathways
are defective in CL mutants, it is tantalizing to think that they identify
possible routes through which CL regulates longevity. Further studies
are required to elucidate the mechanisms connecting PG/CL to cell
wall biogenesis, to the stress response pathways, and to aging.
Finally, how does loss of tafazzin lead to the devastating
consequences in BTHS? What are the physiological modiﬁers that
affect the phenotype associated with tafazzin deﬁciency? While it is
clear that tafazzin remodels CL, the possibility cannot be ruled out that
defective functions in tafazzin deﬁciency that are unrelated to CL may
underlie the pathology in BTHS. The answers to these questions may
shed light on the mechanisms underlying BTHS, and may point the
way to new therapies for this life-threatening illness.
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